Person: MİRİOĞLU, ŞAFAK
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Organizational Unit
Job Title
Last Name
MİRİOĞLU
First Name
ŞAFAK
Name
23 results
Search Results
Now showing 1 - 10 of 23
- PublicationMetadata onlyKronik Böbrek Hastasında Covid-19 Enfeksiyonu Sonrası Gelişen Nefrotik Sendrom: Olgu Sunumu(2021-10-13T00:00:00Z) Abdulhayoğlu, Necat İrem; Gürsu, Meltem; Elçioğlu, Ömer Celal; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; ABDULHAYOĞLU, NECAT İREM; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK
- PublicationMetadata onlyKidney Transplantation in Patients with Hereditary Kidney Diseases(2021-06-04T00:00:00Z) Çalışkan, Yaşar; Güller, Nurane; Dirim, Ahmet Burak; Şafak, Seda; Mirioğlu, Şafak; Yazıcı, Halil; Yıldız, Abdulmecit; Oto, Özgür Akın; Demir, Erol; Özlük, Mesude Yasemin; Türkmen, Aydın; Lentıne, Krista; MİRİOĞLU, ŞAFAK
- PublicationMetadata onlyArteriyovenöz fistüllerin böbrek nakli alıcıları üzerine uzun dönemdeki etkileri(2020-10-15T00:00:00Z) Dirim, Ahmet Burak; Mirioğlu, Şafak; Yazıcı, Halil; Oto, Özgür Akın; Şafak, Seda; Güller, Nurane; Demir, Erol; Türkmen, Aydın; Çalışkan, Yaşar Kerem; Sever, Mehmet Şükrü; MİRİOĞLU, ŞAFAK
- PublicationMetadata onlyOtozomal Dominant Polikistik Böbrek Hastalarında Üriner Sistem Taşı Oluşumuna Eğilim Oluşturan Metabolik Faktörler(2021-10-13T00:00:00Z) Chasan, Onour; Artan, Ayşe Serra; Gürsu, Meltem; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; CHASAN, ONOUR; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
- PublicationMetadata onlyOtozomal Dominant Polikistik Böbrek Hastalığında Total Oksidan/Antioksidan Seviyelerin Böbrek Fonksiyonlarıyla İlişkisi(2021-10-13T00:00:00Z) Aris, Özlem; Büyükaydın, Banu; Artan, Ayşe Serra; Mirioğlu, Şafak; Gürsu, Meltem; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; MİRİOĞLU, ŞAFAK; GÜRSU, MELTEM; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL
- PublicationMetadata onlyDoğru Kan Basıncı Ölçümü İçin İki Yöntemin Karşılaştırılması: Manuel Ölçüm ve Otomatik Cihaz ile Ölçüm(2021-10-13T00:00:00Z) Kuşdoğan, Enes; Artan, Ayşe Serra; Gürsu, Meltem; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; GÜRSU, MELTEM; MİRİOĞLU, ŞAFAK
- PublicationMetadata onlyCOVID-19 pandemisi sırasında periton diyalizi hastalarında teletıp kullanımı(2020-10-15T00:00:00Z) Gürsu, Meltem; Artan, Ayşe Serra; Elçioğlu, Ömer Celal; Mirioğlu, Şafak; Kazancıoğlu, Rümeyza; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZA
- PublicationMetadata onlyKonjenital Böbrek ve/veya Üriner Anomalisi Olan Hastalarda Renal Transplantasyon Sonuçları(2021-10-13T00:00:00Z) Oto, Özgür Akın; Mirioğlu, Şafak; Yazıcı, Halil; Dirim, Ahmet Burak; Güller, Nurane; Şafak, Seda; Demir, Erol; Artan, Ayşe Serra; Özlük, Mesude Yasemin; Çalışkan, Yaşar; Türkmen, Aydın; MİRİOĞLU, ŞAFAK
- PublicationMetadata onlyLIMS1 Risk Genotype and T-Cell Mediated Rejection in Kidney Transplant Recipients.(2021-04-28T00:00:00Z) Çalışkan, Yaşar; Karahan, Gonca; Usta Akgül, Sebahat; Mirioğlu, Şafak; Özlük, Mesude Yasemin; Yazıcı, Halil; Demir, Erol; Dirim, Ahmet Burak; Türkmen, Aydın; Edwards, John; Oğuz Savran, Fatma; Sever, Mehmet Şükrü; Kiryluk, Krzysztof; Gharavi, Ali; Lentine, Krista L; MİRİOĞLU, ŞAFAKBackground:This study aims to examine the association of LIM Zinc Finger Domain Containing 1 (LIMS1) genotype with allograft rejection in an independent kidney transplant cohort.Methods:We genotyped 841 kidney transplant recipients for LIMS1 rs893403 variant by Sanger sequencing followed by PCR confirmation of the deletion. Recipients who were homozygous for LIMS1 rs893403 genotype GG were compared to AA/AG genotypes. The primary outcome was T-cell mediated (TCMR) or antibody mediated rejection (ABMR) and secondary outcome was allograft loss.Results:After a median follow-up of 11.4 years, the rate of TCMR was higher in recipients with the GG (n = 200) compared to AA/AG (n = 641) genotypes [25 (12.5%) vs 35 (5.5%); p = 0.001] while ABMR did not differ by genotype [18 (9.0%) vs 62 (9.7%)]. Recipients with GG genotype had 2.4-times higher risk of TCMR than those who did not have this genotype (adjusted hazard ratio (aHR), 1.442.434.12, p = 0.001). A total of 189 (22.5%) recipients lost their allografts during follow up. Kaplan-Meier estimates of 5-year (94.3% vs. 94.4%, p = 0.99) and 10-year graft survival rates (86.9% vs. 83.4%, p = 0.31) did not differ significantly in those with GG compared to AA/AG groups.Conclusions:Our study demonstrates that recipient LIMS1 risk genotype is associated with increased risk of TCMR after kidney transplantation, confirming the role of LIMS1 locus in allograft rejection. These findings may have clinical implications for the prediction and clinical management of kidney transplant rejection by pretransplant genetic testing of recipients and donors for LIMS1 risk genotype.
- PublicationMetadata onlyThe importance of glomerular C3 accumulation in elderly patients with primary membranous nephropathy(2022-05-01T00:00:00Z) Oto, Özgür Akın; Mirioğlu, Şafak; Dirim, Ahmet Burak; Şafak, Seda; Güller, Nurana; Demir, Erol; Artan, Ayşe Serra; Özlük, Mesude Yasemin; Uçar, Ali Rıza; Soltanova, Lala; Nuriyev, Kanan; Yazıcı, Halil; Çalışkan, Yaşar Kerem; MİRİOĞLU, ŞAFAK
- «
- 1 (current)
- 2
- 3
- »